Funder: National Institutes of Health (NIH)
Due Dates: November 7, 2025 (New, Renewal, Resubmission)
Funding Amounts: Up to $2,000,000 in direct costs per year; maximum project period 5 years; NIAID expects to fund 2–4 awards with a total program budget of $8.3M in FY 2026.
Summary: Supports multi-project Research Centers developing and advancing broadly protective hepatitis C virus (HCV) vaccine candidates toward clinical evaluation; clinical trials not allowed.
Key Information: No clinical trials permitted; foreign organizations may apply but foreign subawards/subcontracts are not allowed.